Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 22, 2026
Should You Buy Exact Sciences Stock Before Nov. 3?
06:53am, Sunday, 02'nd Nov 2025
Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock.
D.A. Davidson & CO. Has $375,000 Stake in Exact Sciences Corporation $EXAS
03:23am, Friday, 31'st Oct 2025
D.A. Davidson and CO. decreased its stake in Exact Sciences Corporation (NASDAQ: EXAS) by 40.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Excha
AlphaQuest LLC Sells 1,364 Shares of Exact Sciences Corporation $EXAS
06:16am, Thursday, 30'th Oct 2025
AlphaQuest LLC reduced its position in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 13.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange
Sumitomo Mitsui Trust Group Inc. Decreases Stake in Exact Sciences Corporation $EXAS
04:53am, Thursday, 30'th Oct 2025
Sumitomo Mitsui Trust Group Inc. reduced its stake in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 69.5% in the second quarter, according to its most recent filing with the Securities and Ex
TEM vs. EXAS: Which Genomics Player Offers Greater Upside?
10:02am, Wednesday, 29'th Oct 2025
Tempus AI's soaring genomics revenues and Exact Sciences' diagnostic breakthroughs spotlight two distinct routes to precision oncology growth.
Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Monday, 27'th Oct 2025
Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced new data being presented at the American College of Ga
DekaBank Deutsche Girozentrale Purchases 217 Shares of Exact Sciences Corporation $EXAS
04:19am, Sunday, 26'th Oct 2025
DekaBank Deutsche Girozentrale boosted its stake in Exact Sciences Corporation (NASDAQ: EXAS) by 0.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchan
Is Exact Sciences (EXAS) Outperforming Other Medical Stocks This Year?
10:41am, Thursday, 23'rd Oct 2025
Here is how Exact Sciences (EXAS) and EssilorLuxottica Unsponsored ADR (ESLOY) have performed compared to their sector so far this year.
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
10:45am, Monday, 20'th Oct 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
5 Growth Stocks to Strengthen Your Portfolio in Q4 After a Fabulous Q3
09:06am, Friday, 10'th Oct 2025
After a stellar Q3 for Wall Street, five growth picks - MU, WDAY, EXAS, EVR, and CDE - stand out with rising earnings estimates.
Here's Why Exact Sciences (EXAS) is a Strong Momentum Stock
10:50am, Thursday, 09'th Oct 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Wednesday, 08'th Oct 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Exact Sciences Schedules Third Quarter 2025 Earnings Call
07:00am, Wednesday, 08'th Oct 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 20
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year?
10:41am, Tuesday, 07'th Oct 2025
Here is how Exact Sciences (EXAS) and Adicet Bio, Inc. (ACET) have performed compared to their sector so far this year.
